Silva, MFBRuiter, JPNIJlst, LAllers, Pten Brink, HJJakobs, CDuran, Mde Almedia, ITWander, RJA2015-12-302015-12-302001ANALYTICAL BIOCHEMISTRY. - Vol. 290, n. 1 (2001), p. 60-670003-2697http://hdl.handle.net/10451/21329A number of valproate adverse reactions are due to its interference with several metabolic pathways, including that of fatty acid oxidation. In order to resolve which mitochondrial enzymes of fatty acid oxidation are inhibited by which VPA intermediates wapplication/pdfengBiochemical Research MethodsBiochemistry & Molecular BiologyChemistry, Analyticaljournal article